BNP Paribas Financial Markets’s Bioventus BVS Stock Holding History

BNP Paribas Financial Markets’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Sell	250,278 -28,889	-10%	-$276K	﹤0.01%	2681
2026 Q1	$2.55M	Sell	279,167 -46,697	-14%	-$392K	﹤0.01%	2515
2025 Q4	$2.42M	Buy	325,864 +77,325	+31%	+$556K	﹤0.01%	2502
2025 Q3	$1.66M	Buy	248,539 +107,934	+77%	+$749K	﹤0.01%	2746
2025 Q2	$931K	Sell	140,605 -21,836	-13%	-$155K	﹤0.01%	2954
2025 Q1	$1.49M	Buy	162,441 +4,424	+3%	+$44.2K	﹤0.01%	2527
2024 Q4	$1.66M	Buy	+158,017	New	+$1.87M	﹤0.01%	2475

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BNP Paribas Financial Markets's BVS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Bioventus (BVS) stake by 10% in Q2 2026, selling an estimated $276K and leaving 250,278 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

BNP Paribas Financial Markets first reported a position in BVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.55M in Q1 2026. 143 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

BNP Paribas Financial Markets held 250,278 shares of Bioventus worth $2.36M as of Q2 2026.
BNP Paribas Financial Markets sold 28,889 Bioventus shares in Q2 2026, an estimated $276K.
Bioventus made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2681 holding.
BNP Paribas Financial Markets first reported a position in Bioventus in Q4 2024 and has held it in 7 quarters since.
BNP Paribas Financial Markets's Bioventus position peaked at $2.55M in Q1 2026.
143 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.